Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Stoke Therapeutics
Biotech
BMS vet answers Foghorn’s call for CBO—Chutes & Ladders
BMS vet answers Foghorn’s call for CBO. Orbital charges up with former Spark CEO. CellCentric secures first CDO.
Darren Incorvaia
,
Zoey Becker
,
Gabrielle Masson
Sep 6, 2024 8:30am
Stoke's Dravet syndrome med released of partial clinical hold
Aug 7, 2024 8:54am
Stoke's shares up 90% as epilepsy drug cuts convulsive seizures
Mar 26, 2024 9:09am
Stoke shares drop 30% as Dravet drug posts high adverse events
Jul 25, 2023 11:49am
Acadia to Stoke up pipeline with $60M CNS research pact
Jan 10, 2022 10:59am
'Leadership is showing': Biotech execs detail being openly LGBTQ
Dec 7, 2021 7:00am